Immunocore Holdings plc (IMCR)

CIK 0001671927 · Healthcare · Biotechnology

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q2-2026 8-K (2026-08-06) · 99.1
Q1-2026 8-K (2026-05-06) · 99.1
Latest FY-2025 8-K (2026-02-25) · 99.1  |  8-K (2026-01-09) · 99.1 · 99.2 · 99.3
Q3-2025 8-K (2025-11-06) · 99.1
Q2-2025 8-K (2025-08-07) · 99.1
Q1-2025 8-K (2025-05-07) · 99.1
FY-2024 8-K (2025-02-26) · 99.1  |  8-K (2025-01-10) · 99.1 · 99.2 · 99.3
Q3-2024 8-K (2024-11-06) · 99.1
Q2-2024 8-K (2024-08-08) · 99.1
Q1-2024 8-K (2024-05-08) · 99.1
FY-2023 8-K (2024-02-28)  |  8-K (2024-01-29) · 99.1 · 99.2  |  8-K (2024-01-05) · 99.1 · 99.2 · 99.3

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover Page
Document and Entity Information
Audit Information
—
Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (P)
Condensed Consolidated Statements of Operations and Comprehensive Income (loss)
—
Consolidated Statements of Operations and Comprehensive Loss
Consolidated Statements of Shareholders' Equity
Consolidated Statements of Cash Flows
Notes
Accrued Expenses and Other Current Liabilities
Basic and Diluted Net (loss) Income Per Share
—
Basic and Diluted Net Income (loss) Per Share
—
Basic and Diluted Net Income Per Share
—
Basic and Diluted Net Loss Per Share
Commitments and Contingencies
Current and Non-current Interest-bearing Loans and Borrowings
—
Cybersecurity Risk Management and Strategy Disclosure
—
Description of Business
Income Taxes
Insider Trading Arrangements
Insider Trading Policies and Procedures
—
Interest-bearing Loans and Borrowings
Leases
—
Non-current Interest-bearing Loans and Borrowings
Pay Vs Performance Disclosure
Prepaid Expenses and Other Current Assets
—
Property and Equipment, Net
—
Revenue
Segment Information
Segment Reporting
—
Share-based Compensation
Shareholders' Equity
—
Subsequent Events
—
Summary of Significant Accounting Policies